目的评价经皮射频毁损治疗肾细胞癌的临床价值。
Objective To evaluate the clinical efficacy of the percutaneous radio frequency (RF) ablation in treatment of renal cell carcinoma.
当前索拉非尼在美国和其他国家被批准用来治疗晚期肾细胞癌。
Sorafenib is currently approved in the United States and other countries for treatment of advanced renal cell carcinoma.
目的：评价手助腹腔镜根治性肾输尿管全切术治疗上尿路移行细胞癌的安全性和有效性。
Objective:To investigate the clinical results of hand-assisted laparoscopic radical nephroureterectomy and evaluate its effectiveness and safety for upper tract transitional cell carcinoma.
目的提高青少年肾细胞癌的诊断和治疗水平。
Objective To improve the diagnosis and treatment of renal cell carcinoma in adolescents.
目的对肾嫌色细胞癌的诊断和治疗进行探讨。
Objective: To discuss the diagnosis and treatment of renal chromophobe cell carcinoma (RCCC).
目的：探讨肾细胞癌的诊断及手术治疗。
Objective: To study the diagnosis and treatment of renal cell carcinoma.
目的：探讨囊性肾细胞癌的诊断和治疗。
Objective: To study the diagnosis and treatment of cystic renal cell carcinoma.
目的研究转人IL2基因对原代肾细胞癌(RCC)细胞致瘤性的影响，为RCC的基因治疗提供依据。
Objective to study the influence on tumorigenicity of human renal cell carcinoma (RCC) cells transduced with human IL 2 gene, and to intend in forming a basis for RCC gene therapy.
VEGF靶向治疗有可能成为肾细胞癌新的辅助治疗标准。
Therapy targeting of VEGF signaling may becomes the new adjuvant treatment standard in RCC.
此研究目的为评估运用积极手术治疗伴血管瘤栓的肾细胞癌患者的临床结果和死亡率。
This study examined the clinical outcome and morbidity of patients with RCC and vascular tumor thrombus treated with aggressive surgical therapy.
目的：探讨偶发性肾细胞癌的治疗方法。
Objective: To discuss the treatment for incidental renal cell carcinoma.
目的：探讨马蹄形肾并发肾细胞癌的诊断与治疗，并结合胚胎发生学进展初步分析其发生的可能原因。
Purpose:To investigate the diagnosis and the treatment of renal cell carcinoma(RCC) in horseshoe kidney and evaluate the relationship between the embryology of the horseshoe kidney and tumorogenesis.
目的探讨多发性肾细胞癌发生的分子生物学机制以及多发性肾细胞癌的诊断与治疗情况。
Objective To discuss the diagnosis, treatments and the mechanism of the molecular biology for multiple renal cell carcinoma (RCC).
吉西他滨和卡培他滨的组合有时用来治疗转移性肾细胞癌。
A combination of gemcitabine and capecitabine is sometimes used to treat metastatic renal cell cancer.
以血管内皮生长因子(VEGF)通路为靶点，抑制肾细胞癌血管生成，已成为肾细胞癌治疗的研究热点。
Therapy targeting for vascular endothelial growth factor (VEGF) signaling can inhibit angiogenesis of RCC, which is one of hot issues in RCC management.
方法回顾性分析482例肾癌患者中22例多房囊性肾细胞癌患者资料，分析其手术治疗的预后特点。
Methods The characteristics of prognosis of surgery in 22 MCRCC cases out of 482 cases of renal cell carcinoma were reviewed.
摘要：目的评估保留肾单位手术(NSS)在肾细胞癌治疗中的应用情况。
ABSTRACT: Objective To evaluate the application of nephron-sparing surgery (NSS) in the treatment of renal cell carcinoma (RCC).
这项治疗的所提高的生存率也只是有限的(大部分都只测试了几个月)，对于肾细胞癌还是带着某种可能的猜测。
The survival benefits of these treatments are relatively modest (usually measured in months), with the possible exception of the benefits for patients with renal-cell carcinoma.
方法回顾性分析5例肾透明细胞癌转移瘤行手术治疗患者的临床资料。
Methods The clinical data of 5 patients with kidney carcinoma after metastasectomy were retrospectively analyzed.
方法回顾性分析我院1991 ~ 2000年收治的269例肾细胞癌患者临床资料，随访治疗效果。
Methods the clinical data of 269 patients with RCC were analyzed from 1991 to 2000 in our hospital, and their results were followed up.
方法回顾性分析我院1991 ~ 2000年收治的269例肾细胞癌患者临床资料，随访治疗效果。
Methods the clinical data of 269 patients with RCC were analyzed from 1991 to 2000 in our hospital, and their results were followed up.
应用推荐